FDA Adverse Event Injury Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 1980213 · Received February 7, 2011

Report

Report Number
2024168-2011-00722
Event Type
Injury
Date Received
February 7, 2011
Date of Event
March 29, 2010
Report Date
January 13, 2011
Manufacturer
AV-TEMECULA-CT
Product Code
NIQ
PMA / PMN Number
P070015
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DURING PROCESSING OF THIS COMPLAINT, ATTEMPTS WERE MADE TO OBTAIN COMPLETE EVENT, PATIENT AND DEVICE INFORMATION. STENT: XIENCE V 2.5 X 28, (1009539-28, LOT#8082762), XIENCE V 4.0 X 18 (1009543-18, LOT#8061261). THERE WAS NO REPORTED PRODUCT DEFICIENCY. ANGINA, ISCHEMIA AND RESTENOSIS ARE KNOWN ADVERSE EVENTS AS LISTED IN THE XIENCE V INSTRUCTIONS FOR USE. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PATIENT EFFECTS AND THEIR RELATIONSHIP, IF ANY, TO THE DEVICES CANNOT BE DETERMINED; THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURE OR DESIGN.

Description of Event or Problem · 1

IT WAS REPORTED VIA A TRIAL THAT APPROXIMATELY FIFTEEN MONTHS POST MULTIPLE XIENCE V STENTING IN THE FIRST POSTEROLATERAL ARTERY, PROXIMAL CIRCUMFLEX (PCX) ARTERY AND THE LEFT MAIN CORONARY ARTERY, THE PATIENT EXPERIENCED DIAPHORESIS, DYSPNEA ON EXERTION AND MILD CHEST TIGHTNESS AND WAS FOUND TO HAVE A POSITIVE FUNCTIONAL STRESS TEST DEMONSTRATING MYOCARDIAL ISCHEMIA. THE PATIENT WAS TREATED WITH MEDICATIONS AND UNDERWENT PERCUTANEOUS CORONARY REVASCULARIZATION IN THE PCX INDEX TARGET LESION FOR IN-STENT RESTENOSIS ON (B)(6) 2010. THE PATIENT'S CONDITION RESOLVED ON (B)(6) 2010 AND THE PATIENT WAS DISCHARGED THE FOLLOWING DAY. THERE WAS NO ADVERSE PATIENT SEQUELA. THOUGH REQUESTED, THERE WAS NO ADDITIONAL INFORMATION PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM DRUG ELUTING CORONARY STENT SYSTEM NIQ AV-TEMECULA-CT 8042461

Patients

Seq Age Sex Outcome Treatment
1 69 YR Hospitalization| R